Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 19, Issue 5, 2004, Pages 1154-1160

  Panichi, Vincenzo ^a   Maggiore, Umberto ^b   Taccola, Daniele ^a   Migliori, Massimiliano ^a   Rizza, Giovanni Manca ^a   Consani, Cristina ^a   Bertini, Alessio ^a   Sposini, Stefano ^c   Perez Garcia, Rafael ^d   Rindi, Paolo ^e   Palla, Roberto ^c   Tetta, Ciro ^f  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c Regional Hospital   (Italy)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e Regional Hospital   (Italy)

^f Research Extracorporeal Therapy   (Germany)

Author keywords

C reactive protein; Cardiovascular mortality; Haemodialysis; Interleukin 6; Outcome

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FOLLOW UP; HEART DEATH; HEMODIALYSIS PATIENT; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 2442551737     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh052     Document Type: Article

References (18)

1. Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979
2. Vasan RS, Sullivan LM, Roubenoff R et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003; 107: 1486-1491
3. Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424
4. Lagrand WK, Visser CA, Hermens WT et al. C-reactive-protein as a cardiovascular risk: more than an epiphenomenon? Circulation 1999; 100: 96-102
5. Bhatt DL, Topol EJ. Need to test the arterial inflammation hypothesis. Circulation 2002; 106: 136-140
6. Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 2001; 19: 143-151
7. Kaysen GA. Role of inflammation and its treatment in ESRD patients. Blood Purif 2002; 20: 70-80
8. Wollert KC, Drexler H. The role of interleukin-6 in the failing heart. Heart Fail Rev 2001; 6: 95-103
9. Bologa RM, Levine DM, Parker TS et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998; 32: 107-114
10. Pecoits-Filho R, Barany P, Lindhom B, Heimburger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002; 17: 1684 1688
11. Hastie TJ, Tibshirani R. Exploring the nature of covariate effects in the proportional hazard model. Biometrics 1990; 46: 1005-1006
12. Royston P, Ambler G. Generalized additive models. Stata Tech Bull 1998; 42: 38-43
13. Grambsch PM, Therneau TM. Proportional hazard tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-526
14. Survival Analysis and Epidemiological Tables. Stata Statistical Manual Release 8.0. Stata Press, College Station, TX; 2003
15. Hosmer DW, Lemeshow S. Applied Survival Analysis. Wiley & Sons, New York; 1999
16. Wanner C, Zimmermann J, Shelder RS, Metzger T. Inflammation and card.iovascular risk in dialysis patients. Kidney Int Suppl 2002; 80: 99-102
17. US Renal Data System. Excerpts from the USRDS 2001 Annual Data Report. Am J Kidney Dis 2001; 38: S1-S248
18. Panichi V, Migliori M, De Pietro S et al. The link of biocompatibility to cytokine production. Kidney Int 2000; 58: S96-S10